Metformin lowers the mitogenic activity of hyperinsulinemia through a reduction in systemic levels of insulin and insulin-like growth factor 1 (IGF-1) and displays an anti-neoplastic effect [25]. The gene discussed is INS; the disease is Hyperinsulinemia.